Gayle Sherman to Anti-HIV Agents
This is a "connection" page, showing publications Gayle Sherman has written about Anti-HIV Agents.
Connection Strength
2,615
-
Motivational interviewing retention counseling and adherence to early infant diagnostic HIV testing schedule in South Africa: The PAEDLINK randomized trial. Medicine (Baltimore). 2022 02 11; 101(6):e28730.
Score: 0,416
-
Monitoring diagnosis, retention in care and viral load suppression in children testing HIV polymerase chain reaction-positive in two districts in South Africa. S Afr Med J. 2019 Aug 28; 109(9):686-692.
Score: 0,351
-
Longitudinal Trajectories of Antiretroviral Treatment Adherence and Associations With Durable Viral Suppression Among Adolescents Living With HIV in South Africa. J Acquir Immune Defic Syndr. 2024 06 01; 96(2):171-179.
Score: 0,122
-
More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2023 12 15; 94(5):412-420.
Score: 0,118
-
Resistance is common in paediatric patients failing ART in South Africa. J Antimicrob Chemother. 2023 05 03; 78(5):1160-1167.
Score: 0,113
-
Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants. Clin Infect Dis. 2022 03 23; 74(6):1047-1054.
Score: 0,105
-
Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis. S Afr Med J. 2022 03 01; 112(3):219-226.
Score: 0,104
-
Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa. S Afr Med J. 2021 Apr 30; 111(5):469-473.
Score: 0,098
-
Impact of breastfeeding, maternal antiretroviral treatment and health service factors on 18-month vertical transmission of HIV and HIV-free survival: results from a nationally representative HIV-exposed infant cohort, South Africa. J Epidemiol Community Health. 2020 12; 74(12):1069-1077.
Score: 0,095
-
Characterizing Viral Load Burden Among HIV-Infected Women Around the Time of Delivery: Findings From Four Tertiary Obstetric Units in Gauteng, South Africa. J Acquir Immune Defic Syndr. 2020 04 01; 83(4):390-396.
Score: 0,091
-
Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study. Lancet HIV. 2019 11; 6(11):e760-e768.
Score: 0,088
-
Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13. BMC Infect Dis. 2019 Sep 16; 19(Suppl 1):787.
Score: 0,088
-
HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy. AIDS. 2019 09 01; 33(11):1751-1756.
Score: 0,088
-
Non-nucleoside reverse transcriptase inhibitor levels among HIV-exposed uninfected infants at the time of HIV PCR testing - findings from a tertiary healthcare facility in Pretoria, South Africa. J Int AIDS Soc. 2019 06; 22(6):e25284.
Score: 0,086
-
Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges. J Int AIDS Soc. 2017 04 10; 20(1):21436.
Score: 0,074
-
Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT. J Glob Health. 2016 Dec; 6(2):020405.
Score: 0,073
-
First population-level effectiveness evaluation of a national programme to prevent HIV transmission from mother to child, South Africa. J Epidemiol Community Health. 2015 Mar; 69(3):240-8.
Score: 0,063
-
Birth diagnosis of HIV infection in infants to reduce infant mortality and monitor for elimination of mother-to-child transmission. Pediatr Infect Dis J. 2013 Oct; 32(10):1080-5.
Score: 0,058
-
The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis. Pediatr Infect Dis J. 2012 May; 31(5):474-80.
Score: 0,053
-
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis. 2012 Jul; 12(7):521-30.
Score: 0,052
-
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA. 2010 Sep 08; 304(10):1082-90.
Score: 0,047
-
Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women. AIDS Res Hum Retroviruses. 2009 Oct; 25(10):1049-53.
Score: 0,044
-
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy. Clin Infect Dis. 2009 Feb 15; 48(4):462-72.
Score: 0,042
-
African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007 Aug 20; 21(13):1753-61.
Score: 0,038
-
Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission. AIDS. 2006 Apr 24; 20(7):995-1002.
Score: 0,035
-
PMTCT from research to reality--results from a routine service. S Afr Med J. 2004 Apr; 94(4):289-92.
Score: 0,030
-
Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa. J Acquir Immune Defic Syndr. 2017 04 01; 74(4):383-389.
Score: 0,019
-
Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE). PLoS One. 2015; 10(7):e0132425.
Score: 0,016
-
Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet. 2002 Mar 23; 359(9311):992-3.
Score: 0,007